Hypertension
Latest News
Bariatric surgery still best option for some with obesity
“Sometimes we might need to go straight to surgery instead of going through medications first, because it may be the most effective and evidence-...
Latest News
At-home blood pressure monitoring is cost effective over long term
Home measurement appeared to be economical over a minimum 10-year period compared with usual care – higher expenditures for equipment and training...
Conference Coverage
More evidence of better outcomes with 120–mm Hg BP target
“We are doing very badly in terms of implementation. There is a big gap between science and what’s happening in the real world.”
Commentary
A better way to control blood pressure
For the American medical-industrial complex, lowered costs for managing common serious diseases may be an undesired rather than a good thing.
Latest News
‘Love more’: Why doctors should promote social connection
Embracing community and close relationships helps people live longer and be happier.
Conference Coverage
Low-salt diet cut BP by 6 mm Hg in 1 week: CARDIA-SSBP
“The blood pressure reduction we see here is ... comparable to that produced by one antihypertensive medication,” said Dr. Deepak Gupta.
Latest News
Risk calculator for early-stage CKD may soon enter U.S. market
Klinrisk, which estimates an adult’s risk for CKD progression from 20 lab values, may spur more targeted, intensified treatment.
Latest News
MASLD, MASH projected to grow by 23% in the U.S. through 2050
“In the absence of effective treatments, health systems should plan for large increases in the number of liver cancer cases and the need for liver...
From the Journals
Standing BP measures improve hypertension diagnosis
“Standing office BP has acceptable discriminative capabilities in identifying the presence of hypertension in adults.”
Feature
How to prescribe exercise in 5 steps
“The most important thing to know about exercise is that finding the time and having the health to do so is a privilege.”
Conference Coverage
Aprocitentan reduces resistant hypertension in CKD
Aprocitentan, a novel dual endothelin antagonist, showed antihypertensive efficacy and manageable safety in people with chronic kidney disease.